Breast Cancer Therapeutics Market Worth US$ 38,573.5 Mn by Top International Players AstraZeneca, Pfizer Inc., Sanofi and more
Jun 11, 2019
The Global Breast Cancer Therapeutics Market, was valued at US$ 17,868.8 Mn in 2018, and is projected to reach US$ 38,573.5 Mn by the end of 2026, exhibiting a CAGR of 10.2%.
Pune, India - June 11, 2019 /MarketersMedia/ —
The increasing number of breast cancer cases all over the world is anticipated to boost the global breast cancer therapeutics market at promising rates, finds Fortune Business Insights in a new study. The study is titled, “Breast Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts”. According to the report, the global breast cancer therapeutics market, which stood at US$ 17,868.8 Mn in 2018, will reach [US$ 38,573.5 Mn] by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.
According to the World Health Organization, in 2018, an approximate of 627,000 women, which is tantamount to 15% of all cancer deaths worldwide, succumbed to breast cancer. The rising incidence of breast cancer is one of the chief drivers of the global breast cancer therapeutics market.
Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/breast-cancer-therapeutics-market-100163
Some of the Main Key Players Covered in the Report
• Genentech (F. Hoffmann-La Roche Ltd)
• Eli Lilly and Company
• Celgene Corporation
• AstraZeneca
• Pfizer Inc.
• Sanofi
• Eisai Co. Ltd.
• Kyowa Kirin
• Bristol Myers Squibb
• Mayne Pharma Group Limited
• Valeant Pharmaceuticals
High Intake of Oral Contraceptives Among Women, Boosting Market
Breast cancer can develop due to reasons such as reduced breast feeding, rise in age of childbearing, undergoing estrogen modifying drug treatments and high intake of oral contraceptive pills. The increase in the number of women complaining of such problems and the successive rise in the number of breast cancer cases are factors boosting the global market for breast cancer therapeutics during the forecast period.
Another factor creating lucrative growth opportunities for breast cancer therapies is the increasing number of obese women. With change in lifestyle and unhealthy food habits, the rate of obesity is increasing by the day. Obesity further causes various health problems such as cardiovascular disorders, gall bladder diseases, diabetes, breathing problems, and breast cancer among others.
However, some breast cancer drugs may have serious side effects and this may act as a hindrance to the market. Besides this, countries that lack of awareness may restrict expansion of the market. Also social taboos prevalent in these countries may act as major deterrents to growth.
Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/breast-cancer-therapeutics-market-100163
Nevertheless, the rate of demographic transition all around the world and advent of advanced diagnostic screening programs are creating growth opportunities for the market. Also government initiatives aimed at spreading awareness about breast cancer will bode well for the market.
North America to Remain Dominant on Account of Presence of Skilled Professionals
The breast cancer treatment market in North America is currently leading the global landscape, supported by the presence of a well-established healthcare infrastructure and rising uptake of advanced facilities in the region. In 2018, North America generated a revenue of US$ 8,033.8 Mn, because of the increasing prevalence of breast cancer in the region. In addition to this, the region boasts presence of several leading market players and skilled professionals. Besides this, governments of developed nations such as Canada and the U.S. are providing health insurance for cancer diagnostics. Spurred by these factors the breast cancer therapeutics market is likely to flourish in North America to emerge dominant.
Looming Patent Expiries Fuels Demand for Generic Drugs
The global breast cancer therapeutics market is likely to witness the prevalence of high competition. According to the report, Genentech, Inc. (F. Hoffmann-La Roche Ltd) held the dominant share in the market in 2018. Growth of the company is backed by its diverse product portfolio in targeted and chemotherapy segment.
With the expiry of most patent drugs in the market, there is an increased demand for their generic counterparts. Such factors are propelling vendors to invest more on research and development and develop generic drugs for breast cancer treatment. The introduction of combination drug therapy is anticipated to create better growth opportunities for the market. Some of the players operating in the global breast cancer therapeutics market are Puma Biotechnology, Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Eli Lilly and Company, Novartis International AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Sanofi S.A.,
GlaxoSmithKline plc, and Pfizer, Inc.
Major Table of Content for Breast Cancer Therapeutics Market:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions andAssumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of BreastCancer Therapeutics by Key Countries
4.2 Regulatory Scenario byKey Regions
4.3 Key IndustryDevelopments
4.4 Overview of CurrentAdvances in R&D for Breast Cancer Therapeutics
5. Global Breast Cancer Therapeutics Market Analysis, Insights and Forecast,2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis,Insights and Forecast – By Therapy
5.2.1Targeted Therapy
5.2.1.1 Abemaciclib
View More Related Reports:
Hereditary Angioedema Treatment Market by Size, Share, Analysis, Insights, Technological Developments in Treatment Foresight till 2025
Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.
Phone: 14242530390
Website: https://www.fortunebusinessinsights.com
Source: MarketersMedia
Release ID: 522446
China routes emerge as key revenue source for struggling Korean LCCs
China is emerging as a critical earnings lifeline for Korea’s struggling low-cost carriers (LCCs), offering them access to fast-growing passenger demand and lucrative business traffic as growth in other short-haul markets loses steam. Some 2.13 million passengers traveled between Korea and China in August, surpassing the previous monthly record of about 2.07 million set in August 2016, before the fallout from the deployment of a U.S. missile defense system in Korea severely disrupted bilateral tourism. The August figure was up 27.5 percent from a year earlier and 9.7 percent from July, according to data from the Ministry of Land, Infrastructure and Transport. The rebound comes as Korean airlines are gaining access to some of the most commercially attractive China routes. In the latest allocation of traffic rights, the government gave major LCCs additional slots on routes linking Seoul with Beijing and Shanghai, as well as Guangzhou, Dalian and other Chinese cities. Jeju Air and Eastar Jet each secured seven weekly flights on the Incheon-Beijing route, while Parata Air and Air Premia re
Coupang dispute raises stakes in Korea's $350 bil. US investment talks
Korean regulators’ hardline stance toward Coupang is complicating Seoul’s talks with Washington over the next stages of its planned $350 billion investment in the United States. The latest development came Wednesday when the Seoul High Court rejected Coupang’s request to suspend the effect of a Fair Trade Commission (FTC) decision ordering an on-site inspection of the U.S.-headquartered e-commerce firm’s alleged violations of a local fair transaction act. Coupang had refused to cooperate with the probe, arguing that the FTC failed to provide advance notice. The court ruling allows the FTC to proceed with the investigation. FTC Chairman Ju Biung-ghi has vowed to review the agency’s internal rules to close what he described as loopholes that allow companies to delay or evade investigations through court injunctions. He has also rejected U.S. criticism that the regulator is discriminating against American companies, saying the FTC will continue to enforce Korean law without regard to nationality. The confrontation is particularly sensitive, as Korea and the U.S. work to flesh out t
Trump: Xi 'seemed to like' calling AI 'super intelligence'
President Trump said on Friday that Chinese President Xi Jinping appeared to like referring to artificial intelligence as “super intelligence” days after Trump announced the U.S. would be using the new name in official documents and communications. Trump made the observation in a Truth Social post in which he referred to his meeting with the...
Google DeepMind’s AlphaGenome Atlas could help researchers find the genetic causes of diseases
AlphaGenome Atlas contains predictions for the molecular effects of all roughly 9 billion possible single-letter changes in human DNA. Researchers can search the database to see how individual variants are predicted to affect processes such as gene expression, RNA splicing, and chromatin accessibility across different cell types and tissues. That gives researchers something they have
Software fix for the iPhone 18 Pro’s Face ID freezing and rebooting issue is coming next week
A small number of users are said to be facing issues with their new iPhone’s Face ID system.
Ecosystem Roundup: Seoul tops AI implementation as Singapore joins the global top tier
San Francisco and New York still lead The Observer‘s inaugural AI Cities Index, but the more consequential finding sits further east. Six of the world’s top 10 AI cities are in East and Southeast Asia, and Seoul ranks first globally for implementation: whether a city has the institutions, systems and practitioners to put AI to work across […] The post Ecosystem Roundup: Seoul tops AI implementation as Singapore joins the global top tier appeared first on e27.
Xi at White House, trade-war truce extension, Golden Week travel
Chinese President Xi Jinping and US President Donald Trump discussed artificial intelligence (AI) and Taiwan at the White House on Thursday as part of a state visit dominated by pageantry. On AI, Xi said that “the right thing to do is to draw on each other’s strengths, not guard against each other”, according to a statement from the Chinese foreign ministry. He also backed continued dialogue about risks, joint efforts to prevent misuse and keeping AI under human control. Trump earlier said on...
What MARINA’s system failure reveals about government readiness
MANILA, Philippines — In the digital age, it only takes one cyberattack to bring a government service to a halt. When the Maritime Industry Authority’s (MARINA) seafarer document system was hit, the disruption exposed a problem beyond the attack itself: an aging digital infrastructure that had been waiting years for an upgrade. The agency temporarily
Xi-Trump dinner puts US tech titans in spotlight – what does it mean for China ties?
If the American guests seated at the head table with President Xi Jinping and US President Donald Trump at Thursday’s White House state dinner were any indication, Washington now views its relationship with Beijing largely through the prism of technology. Analysts said the seating arrangement underscored how tech industry titans driving the global AI infrastructure boom were pushing to draw the two economic superpowers closer together. Sitting alongside Xi, Chinese first lady Peng Liyuan, Trump...
HWZ Tech Awards 2026 Readers’ Choice - Vote and Win!
Voting for the HardwareZone Tech Awards 2026 Readers’ Choice is now open! Stand a chance to win $3,000 worth of Grab Vouchers!
UAAP Esports eyes main event status after quick success
MANILA, Philippines – UAAP Esports is no longer content with proving that esports belong in the collegiate sports scene. It now wants to prove that it can draw the same respect, attention, and energy as the league’s biggest events. Don’t call it just another sport, esports is a main event. At least, that’s what the
Altcoins are running on real news, Wall Street is running on fear
Asian stocks and bonds fell as a global bond selloff deepened and inflation fears intensified, with oil prices remaining elevated. Regional indices pointed lower in early trading. Wall Street had finished a volatile session mixed to flat. The S&P 500 edged slightly lower. The Dow Jones Industrial Average dropped 161 points, or 0.3 per cent. […] The post Altcoins are running on real news, Wall Street is running on fear appeared first on e27.
Trump rules out Bessent as AI czar
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.